Luxiq

— THERAPEUTIC CATEGORIES —
  • Topical steroids

Luxiq Generic Name & Formulations

General Description

Betamethasone valerate 0.12%; foam; contains alcohol.

How Supplied

Foam—50g, 100g

Manufacturer

Generic Availability

YES

Luxiq Indications

Indications

Corticosteroid-responsive scalp dermatoses.

Luxiq Dosage and Administration

Adult

Apply twice daily (AM & PM). Invert can and dispense a small amount onto a clean saucer or other cool surface. Pick up small amount of foam and massage into affected areas until foam disappears; repeat until entire affected scalp area is treated. Reevaluate if no improvement after 2 weeks. Do not occlude.

Children

Not recommended.

Luxiq Contraindications

Contraindications

Do not use superpotent forms on face, groin, or axillae. Exclude viral disease (eg, chickenpox, measles).

Luxiq Boxed Warnings

Not Applicable

Luxiq Warnings/Precautions

Warnings/Precautions

Treat infection if present; discontinue if infection persists or worsens. Do not use near eyes, or on diaper dermatitis or pre-existing skin atrophy. Do not use fluorinated steroids longer than 1 week on the face. Avoid abrupt cessation in chronic use. Systemic absorption increased by broken or inflamed skin, prolonged use, application to large surface area, or use of occlusive dressings. Occlude only if necessary; do not occlude higher potency products. Monitor adrenal function in children if a high potency product or occlusion is used, and in adults if more than 50g weekly of a high potency product is used. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, glucosuria, or irritation occurs. Use lowest effective dose and potency (esp. in children). Use caution if applying to face or body folds. Do not use continuously or for prophylaxis. Foams are flammable. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.

Luxiq Pharmacokinetics

See Literature

Luxiq Interactions

Not Applicable

Luxiq Adverse Reactions

Adverse Reactions

Burning, stinging, pruritus, erythema, skin atrophy, striae, miliaria, secondary infections, hypopigmentation, folliculitis, hypertrichosis, acneiform eruptions, dermal cracking and fissuring, telangiectasia, contact dermatitis, other local effects, immunosuppression, masks infections, HPA axis suppression (esp. in children).

Luxiq Clinical Trials

See Literature

Luxiq Note

Not Applicable

Luxiq Patient Counseling

See Literature